On May 18th, the People’s Vaccine Alliance sent Justin Trudeau, Prime Minister of Canada, a letter urgently requesting that vaccines, therapeutics and diagnostics for COVID-19 be added to Schedule 1 of the Patent Act. Below is the text of the PVA… Continue Reading
On Monday, 17 May 2021, the 62 co-sponsors of a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19 (IP/C/W/669) published a joint statement (IP/C/W/677) on COVID-19. This joint statement foreshadows the revised… Continue Reading
Allele is accusing Pfizer and BioNTech of infringing one of their patents during the research that led to their COVID-19 vaccine, according to a complaint recently filed in a federal court in California, United States. The case relates to U.S.… Continue Reading
On April 27th, a letter signed by 41 Canadian experts was sent to the Prime Minister of Canada, the Minister of Innovation, Science & Industry, and the Minister of Health. The letter requests the amendment of Schedule 1 of the… Continue Reading
On 4 December 2020, Ethiopia submitted a Zero Draft resolution to the World Health Organization (WHO) on Strengthening Local Production of Medicines and Other Health Technologies to Improve Access – WHO Resolution on Strengthening Local Production of Medicines and Other… Continue Reading
On March 31, 2020, KEI received a copy of the contract between Johnson & Johnson (“J&J”) and the Department of Health and Human Services (HHS) for the development of J&J’s COVID-19 vaccine.The contract, which is now valued at $1.3 billion,… Continue Reading
A March 21, 2021 New York Times article on vaccine access discusses how a technology invented and owned by the National Institutes of Health (NIH) is necessary to make several COVID-19 vaccines. The invention mentioned by the Times, titled Prefusion… Continue Reading
Negotiating texts for WHA 74 on local production. 4 December 2020. Concept Note (Text prepared by Ethiopia) Zero Draft resolution on Strengthening Local Production of Medicines and Other Health Technologies to Improve Access, Dec 04,2020 – WHO Resolution on Strengthening… Continue Reading
On March 11th 2021, Biolyse Pharma (“Biolyse”) issued a statement publicly indicating their capacity to manufacture a COVID-19 vaccine and their intent to apply for a compulsory license in Canada. Biolyse is a Canadian manufacturer of cancer drugs based out… Continue Reading